Cardinal Health, Inc. (CAH)
| Previous close | 103.04 |
| Open | 102.25 |
| Bid | 102.63 x 1200 |
| Ask | 102.70 x 1200 |
| Day's range | 100.56 - 103.06 |
| 52-week range | 77.56 - 116.04 |
| Volume | |
| Avg. volume | 2,260,481 |
| Market cap | 25.068B |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | 40.90 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.00 (1.94%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | N/A |
- PR Newswire
Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts
Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its fiscal 2024 non-GAAP diluted EPS guidance of $7.20 to $7.35. Despite the nonrenewal of the OptumRx contracts, the company also reiterated both its Pharmaceutical and Specialty Solutions long-term segment profit CAGR target of 4% to 6% and its consolidated non-GAAP EPS CAGR target of 12% to 14% for fiscal yea
- PR Newswire
Cardinal Health announces location of pharmaceutical distribution center for over-the-counter products
Today, Cardinal Health (NYSE: CAH) announced that construction has begun for a new 350,000 square-foot logistics center in Columbus, Ohio, that will serve as a centralized replenishment center for the distribution of over-the-counter consumer health products in support of its core pharmaceutical business.
- PR Newswire
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2024 on May 2
Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
